"Cholinergic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.
| Descriptor ID |
D018678
|
| MeSH Number(s) |
D27.505.519.625.120 D27.505.696.577.120
|
| Concept/Terms |
Cholinergic Agents- Cholinergic Agents
- Agents, Cholinergic
- Cholinergics
- Acetylcholine Agents
- Agents, Acetylcholine
- Cholinergic Drugs
- Drugs, Cholinergic
Nicotinic Effect- Nicotinic Effect
- Effect, Nicotinic
- Nicotinic Effects
- Effects, Nicotinic
Cholinergic Effect- Cholinergic Effect
- Effect, Cholinergic
- Cholinergic Effects
- Effects, Cholinergic
Muscarinic Effect- Muscarinic Effect
- Effect, Muscarinic
- Muscarinic Effects
- Effects, Muscarinic
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Agents".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Agents".
This graph shows the total number of publications written about "Cholinergic Agents" by people in this website by year, and whether "Cholinergic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholinergic Agents" by people in Profiles.
-
Cholinergic regulation of striatal dopamine release: New light in dark basements. Mov Disord. 2016 12; 31(12):1796.
-
Is recurrent perseveration a product of deafferented functional systems with otherwise normal post-activation decay rates? Clin Linguist Phon. 2011 Nov; 25(11-12):1066-73.
-
An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2009 Aug; 2(4):384-92.
-
Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane. J Biol Chem. 2004 Jul 02; 279(27):28266-75.
-
What's hot, what's not, in dementia drugs? Part I: Cholinergic therapies. J Gerontol Nurs. 1997 Sep; 23(9):52-4.
-
AMITRIPTYLINE AND NORTRIPTYLINE AS ANTAGONISTS OF CENTRAL AND PERIPHERAL CHOLINERGIC ACTIVATION. Psychopharmacologia. 1963 Apr 16; 4:114-25.